Fontan Considerations I

Who Does Well and Why: Understanding Prognosis in Fontan.
Presented by Aleksander Kempny, MD
Barts Heart Centre, London, UK

kempny-aleksanderDr Aleksander Kempny is a Cardiologist for Adult Congenital Heart Disease at the Barts Heart Centre (formerly the Heart Hospital) in London, UK. He trained at the University Hospital in Muenster, Germany and at the Royal Brompton Hospital in London, UK. He is board certified in internal medicine, cardiology and echocardiography (ESC). His academic interest includes outcome analysis in patients with congenital heart disease as well as myocardial deformation analyses on echocardiography and MRI.  Dr Kempny’s main clinical interest includes management of patients with congenital heart disease, with particular focus on patients with coexisting pulmonary hypertension, patients with cyanotic lesions and Fontan circulation.


How Do We Define “Fontan Failure”?
Presented by Luke Burchill, MBBS PhD

burchill-lukeDr. Luke J Burchill MBBS PhD is an Assistant Professor of Medicine and Cardiologist in the Adult Congenital Heart Disease Program at the Knight Cardiovascular Research Institute, Oregon Health Science University (Portland, Oregon, USA). He received his medical degree and doctor of philosophy from the University of Melbourne (Melbourne, VIC, Australia) and subsequently completed postdoctoral fellowships in Adult Congenital Heart Disease (ACHD), Advanced Heart Failure & Heart Transplantation (Toronto General Hospital, ON, Canada), & Echocardiography (Cleveland Clinic, OH, USA). Dr. Burchill has made original contributions in the area of hormonal and genetic heart failure mechanisms, heart failure in ACHD, health care transitions for adolescents with ACHD, quality of life, and transplant outcomes in ACHD patients.


Latest Rationale and Data on Pulmonary Vascular Therapy in Fontan.
Presented by Jamil Aboulhosn, MD
Ahmanson/UCLA Adult Congenital Heart Disease Center

aboulhosn-jamilDr. Jamil Aboulhosn is the Director of the Ahmanson/UCLA Adult Congenital Heart Disease Center and an Associate Professor of Medicine and Pediatrics at UCLA.  He is also the Streisand/AHA endowed Chair in Cardiology.  He received his medical degree at the University of California Los Angeles and subsequently completed training in internal medicine, cardiovascular medicine at Harbor-UCLA followed by fellowships in adult congenital heart disease and congenital interventional cardiology at UCLA.  Dr. Aboulhosn has made numerous contributions in the areas of pulmonary hypertension, trans-catheter interventions and cardiovascular imaging.


“Double Double Coil and Trouble”: When and Why Should Collaterals Be Closed?
Presented by William Wilson, MBBS (Melb), FRACP
Royal Melbourne Hospital (Australia)

William WilsonWill completed general medicine and cardiology training at the Royal Melbourne Hospital, Australia. He undertook a fellowships in coronary intervention at the Royal Infirmary of Edinburgh (Scotland) and in adult congenital heart disease at the Toronto Congenital Cardiac Centre for Adults. He started as a consultant interventional cardiologist at the Royal Melbourne Hospital in 2014. He is currently undertaking a PhD at the University of Melbourne with a focus on adult congenital heart disease.

What Do We Do With the Liver? A Report from the “Fontan  and Liver Disease” ACC Consortium.

Presented by Curt Daniels, MD
Nationwide Children’s Hospital

daniels-curtCurt J. Daniels, MD is a Professor of Clinical Internal Medicine and Pediatrics in the Division of Cardiology at The Ohio State University and the Division of Pediatric Cardiology at Nationwide Children’s Hospital. He is the Dottie Dohan Shepard Chair in Cardiovascular Medicine and the Director of the COACH program: Columbus Ohio Adult Congenital Heart Disease and Pulmonary Hypertension Program. Dr. Daniels is board certified in both pediatric cardiology and internal medicine cardiology. He serves on the Adult Congenital/Pediatric Cardiology Council and is the Co-Chair of the ACHD Working Group of the American College of Cardiology. In addition, Dr. Daniels serves as Chair of the Adult Congenital Heart Association Medical Advisory Board, and is Chair of the ACHA Program Accreditation Committee. Dr. Daniels is committed to education and has developed a fellowship training program for ACHD with over 10 fellow graduates, many of which have started new ACHD programs across the US. He has also worked to develop a subspecialty board certification in ACHD and currently serves as the Chair of the ABIM ACHD Subspecialty Board.  For the past 10 years Dr. Daniels has led a bi-monthly regional patient education lecture series for ACHD patients and has led the effort to provide a personalized electronic medical record for all patients followed in the ACHD program. Dr. Daniels has designed, implemented and successfully completed multiple ACHD research studies and presented his research nationally. In collaboration with colleagues from The Ohio State University and Nationwide Children’s Heart Center he has mentored fellows training thru the NIH T32 Training Grant entitled “Training in Congenital Heart Disease.” In 2011 Dr. Daniels was elected President of the International Society for ACHD with a focus on developing Global Health Initiatives for ACHD.  In 2014, he was selected as Co-Chair of the ACC/AHA ACHD Care Guidelines.

(No Ratings Yet)